Bay Street News, December, 2018

Achieved statistical significance on primary imaging-based endpoint, changes in markers of central pain processing, in 11 subjects Observed corresponding trends […]

HOUSTON, Dec. 03, 2018 (GLOBE NEWSWIRE) — Bio-Path Holdings, Inc., (NASDAQ: BPTH), a biotechnology company leveraging its proprietary DNAbilize® antisense […]

CG-806 Pan-FLT3/Pan-BTK Inhibitor Exhibits Favorable Safety Profile and Unexpected Potency on Primary Cells from B-cell Cancer Patients and AML Patients […]

— 27% of subjects achieved 75% reduction in PASI score (PASI 75) vs 13% with vehicle; 29% of subjects achieved […]

Data elucidate unique ability of CG-806 to overcome resistance to other FLT3 inhibitors in AML cells SAN DIEGO and TORONTO, […]

LONDON and WALTHAM, Mass., Dec. 03, 2018 (GLOBE NEWSWIRE) — GlaxoSmithKline plc (LSE/NYSE: GSK) and TESARO Inc (NASDAQ: TSRO) today […]

Combined power of Rulebook acquisition and Sequel enhances Verisk’s position as a leading provider of insurance software solutions to the […]

The ERADICATE Hp2 confirmatory Phase 3 study successfully met its primary endpoint of H. pylori eradication (84% vs. 58%) with […]

Potential Novel Target Discovery VANCOUVER, British Columbia, Dec. 03, 2018 (GLOBE NEWSWIRE) — Nash Pharmaceuticals Inc., a wholly owned subsidiary […]

HORSHAM, Pa., Dec. 03, 2018 (GLOBE NEWSWIRE) — In recognition of the December 5, 2018 National Day of Mourning for […]